Skip to Content

Medications for Polymyositis/Dermatomyositis

About Polymyositis/Dermatomyositis:  A connective tissue disease, which is characterized by inflammation and degeneration of the muscles.

Drugs Used to Treat Polymyositis/Dermatomyositis

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
prednisone C N 1 review
9.0

Generic name: prednisone systemic

Drug class: glucocorticoids

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

immune globulin intravenous Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Brand names:  Carimune, Gammagard S / D, Flebogamma, Gamimune, Gammaplex, Octagam, Polygam S / D, Sandoglobulin, Gamimune N 5%, Gammar-P I.V., Iveegam En, Panglobulin NF …show all

Drug class: immune globulins

For consumers: dosage, interactions,

Off Label: Yes

corticotropin C N 1 review
3.0

Generic name: corticotropin systemic

Brand name:  H.P. Acthar Gel

Drug class: corticotropin

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

Carimune Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Off Label: Yes

H.P. Acthar Gel C N 1 review
3.0

Generic name: corticotropin systemic

Drug class: corticotropin

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Gammagard S / D Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

Off Label: Yes

Flebogamma Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Off Label: Yes

Gamimune Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

Off Label: Yes

Gammaplex Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Off Label: Yes

Octagam Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Off Label: Yes

Polygam S / D Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

Off Label: Yes

Sandoglobulin Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

Off Label: Yes

Gamimune N 5% Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

Off Label: Yes

Gammar-P I.V. Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

Off Label: Yes

Iveegam En Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

Off Label: Yes

Panglobulin NF Off Label C N Add review Rate

Generic name: immune globulin intravenous systemic

Drug class: immune globulins

For consumers: dosage, interactions, side effects

Off Label: Yes

Page 1

Learn more about Polymyositis/Dermatomyositis

IBM Watson Micromedex

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide